ChenGuang Biotech Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,284	1,459	1,802	1,422	1,147	732.59
Short-Term Investments	-	9.81	14.01	17.02	13.75	5.07
Trading Asset Securities	106.87	54.66	8.13	79.85	17.58	0.56
Cash & Short-Term Investments	3,391	1,523	1,825	1,519	1,178	738.22
Cash Growth	3.50%	-16.51%	20.09%	28.98%	59.57%	136.70%
Accounts Receivable	483.65	500.68	458.39	474.39	311.4	398.77
Other Receivables	95.85	94.78	9.54	17.17	77.56	12.63
Receivables	579.51	595.46	467.93	491.56	388.96	411.4
Inventory	3,982	4,229	3,862	3,198	2,033	2,229
Prepaid Expenses	-	-	-	-	1.48	0.01
Other Current Assets	1,079	1,084	654.03	1,157	1,325	598.8
Total Current Assets	9,032	7,431	6,809	6,367	4,927	3,977
Property, Plant & Equipment	1,516	1,526	1,663	1,696	1,538	1,484
Long-Term Investments	121.23	114.6	112.71	101.47	92.25	173.01
Goodwill	0.59	0.59	0.59	0.59	0.59	0.59
Other Intangible Assets	320.78	323.55	337.01	304.19	308.9	265.71
Long-Term Deferred Tax Assets	54.92	55.19	56.56	44.39	35.79	31.54
Long-Term Deferred Charges	2.31	2.33	8.88	12.63	6.75	3.93
Other Long-Term Assets	44.67	50.62	35.21	13.89	14.32	19.83
Total Assets	11,092	9,504	9,023	8,540	6,924	5,955
Accounts Payable	86.25	73.27	153.85	79.53	55.96	36.09
Accrued Expenses	96.1	131.57	117.45	122.58	146.93	105.49
Short-Term Debt	5,607	4,111	2,304	2,599	2,043	1,839
Current Portion of Long-Term Debt	960.48	958.59	1,537	750.56	0.62	300.52
Current Portion of Leases	-	1.05	0.23	0.22	0.21	0.06
Current Income Taxes Payable	24.88	21.07	18.82	41.16	41.82	18.22
Current Unearned Revenue	350.72	335.48	335.29	236.04	365.61	307.91
Other Current Liabilities	167.73	149.96	129.95	123.01	102.82	75.03
Total Current Liabilities	7,293	5,782	4,596	3,952	2,757	2,682
Long-Term Debt	45	50	1,068	865	770	303.1
Long-Term Leases	0.94	0.93	3.56	3.79	4	2.67
Long-Term Unearned Revenue	173.08	175.19	150.44	117.72	93.69	83.6
Long-Term Deferred Tax Liabilities	21.16	21.52	14.7	16.57	16.64	14.56
Other Long-Term Liabilities	35.79	35.37	35.12	52.23	68.08	85.79
Total Liabilities	7,569	6,065	5,868	5,007	3,710	3,172
Common Stock	483.1	483.1	483.1	532.77	532.77	532.77
Additional Paid-In Capital	579.5	579.5	581.98	1,022	1,022	1,025
Retained Earnings	2,491	2,394	2,085	2,056	1,662	1,294
Treasury Stock	-	-	-	-95.84	-	-
Comprehensive Income & Other	-81.27	-67.36	-40.87	-44.2	-51.43	-67.2
Total Common Equity	3,472	3,389	3,109	3,470	3,165	2,785
Minority Interest	51.55	49.87	45.2	61.79	49.26	-2.1
Shareholders' Equity	3,523	3,439	3,155	3,532	3,214	2,783
Total Liabilities & Equity	11,092	9,504	9,023	8,540	6,924	5,955
Total Debt	6,613	5,122	4,912	4,218	2,818	2,445
Net Cash (Debt)	-3,222	-3,599	-3,088	-2,699	-1,640	-1,707
Net Cash Per Share	-6.67	-7.45	-5.97	-5.07	-3.08	-3.23
Filing Date Shares Outstanding	483.12	483.1	483.1	532.77	532.77	532.77
Total Common Shares Outstanding	483.12	483.1	483.1	532.77	532.77	532.77
Working Capital	1,739	1,649	2,213	2,415	2,170	1,295
Book Value Per Share	7.19	7.02	6.44	6.51	5.94	5.23
Tangible Book Value	3,151	3,065	2,772	3,166	2,855	2,519
Tangible Book Value Per Share	6.52	6.34	5.74	5.94	5.36	4.73
Buildings	-	983.26	968.65	865.58	-	709.91
Machinery	-	1,582	1,549	1,359	-	1,139
Construction In Progress	-	73.46	112.43	295.48	-	219.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.